Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001―2009)

Quality-of-life (QOL) measurement is often incorporated into randomized clinical trials in breast cancer. The objectives of this systematic review were to assess the incremental effect of QOL measurement in addition to traditional endpoints (such as disease-free survival or toxic effects) on clinica...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2011-02, Vol.103 (3), p.178-231
Hauptverfasser:	LEMIEUX, Julie, GOODWIN, Pamela J, BORDELEAU, Louise J, LAUZIER, Sophie, THEBERGE, Valérie
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Biological and medical sciences Breast cancer Breast Neoplasms - pathology Breast Neoplasms - therapy Chemotherapy, Adjuvant - adverse effects Clinical trials Disease-Free Survival Female Gynecology. Andrology. Obstetrics Health Status Humans Mammary gland diseases Medical Records Medical sciences Morbidity Oncology Quality of Life Radiotherapy, Adjuvant - adverse effects Randomized Controlled Trials as Topic Surveys and Questionnaires Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!